Program and Abstracts from the Canadian Digestive Diseases Week 2016

Table 31

Characteristics of PSC Patients According to Baseline sIgG4 Concentration.

	Normal sIgG4	Elevated sIgG4	-value
	(≤140 mg/dL)	(>140 mg/dL)
	()	()
Age, years	44 (37–51)	49 (38–59)	0.046
Male	63% (126)	68% (23)	0.70
White race	84% (168)	97% (33)	0.058
Ulcerative colitis	46% (91)	56% (19)	0.27
UDCA use	60% (119)	59% (20)	>0.99
ALT, U/L	64 (36–112)	58 (35–123)	0.60
Alkaline phosphatase, U/L	260 (127–399)	262 (158–430)	0.31
GGT, U/L	236 (93–495)	252 (114–662)	0.50
Bilirubin, μmol/L	0.7 (0.5–1.1)	0.7 (0.5–1.0)	0.92
INR	1.0 (0.9–1.0)	1.0 (0.9–1.0)	0.88
Albumin, g/dL	4.1 (3.8–4.3)	3.8 (3.5–4.2)	0.010
Platelets, ×10^3/μL	248 (196–306)	282 (237–347)	0.030
FibroTest	0.41 (0.23–0.58)	0.48 (0.24–0.64)	0.20
ELF	9.46 (8.54–10.33)	9.46 (8.84–10.84)	0.25
Serum LOXL2, pg/mL	100 (70–146)	113 (88–155)	0.18
Ishak 3–6 fibrosis	50% (100)	56% (19)	0.58
MELD	7 (6–8)	6.5 (6–8)	0.81
Mayo risk score	–0.135 (–0.615, 0.365)	0.015 (–0.47, 1.11)	0.15

All data are median (IQR) or % ().